{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:53:22Z","timestamp":1772916802798,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.tiv.2011.04.010","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T16:21:58Z","timestamp":1303230118000},"page":"1414-1424","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of a genomic and a multiplex cell imaging approach for the detection of phospholipidosis"],"prefix":"10.1016","volume":"25","author":[{"given":"K.","family":"Tilmant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.H.J.","family":"Gerets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Dhalluin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hanon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Depelchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cossu-Leguille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Vasseur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.A.","family":"Atienzar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2011.04.010_b0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/toxsci\/kfl184","article-title":"Determination of phospholipidosis potential based on gene expression analysis in HepG2 Cells","volume":"96","author":"Atienzar","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2011.04.010_b0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/01926230701196414","article-title":"Letter to the editor","volume":"35","author":"Berridge","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tiv.2011.04.010_b0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/adt.2007.119","article-title":"Phospholipidosis assay in HepG2 cells and rat or rhesus hepatocytes using phospholipid probe NBD-PE","volume":"6","author":"Bhandari","year":"2008","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.tiv.2011.04.010_b0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/toxsci\/kfn008","article-title":"Role of tissue kallikrein in prevention and recovery of gentamicin-induced renal injury","volume":"102","author":"Bledsoe","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2011.04.010_b0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1024778329320","article-title":"A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development","volume":"19","author":"Casartelli","year":"2003","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.tiv.2011.04.010_b0030","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1177\/0192623309352496","article-title":"A strategy for risk management of drug-induced phospholipidosis","volume":"37","author":"Chatman","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tiv.2011.04.010_b0035","first-page":"116","article-title":"Lysosomal alterations in cultured macrophages exposed to anorexigenic and psychotropic drugs","volume":"35","author":"Drenckhahn","year":"1976","journal-title":"Lab. Invest."},{"key":"10.1016\/j.tiv.2011.04.010_b0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1517\/14740338.7.2.107","article-title":"The role of early in vivo toxicity testing in drug discovery toxicology","volume":"7","author":"Fielden","year":"2008","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.tiv.2011.04.010_b0045","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1378\/chest.107.6.1763","article-title":"Fluoxetine hydrochloride (Prozac)-induced pulmonary disease","volume":"107","author":"Gonzalez-Rothi","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.tiv.2011.04.010_b0050","first-page":"90","article-title":"Early toxicity screening strategies","volume":"12","author":"Greene","year":"2009","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"10.1016\/j.tiv.2011.04.010_b0055","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/1087057110376413","article-title":"Early safety assessment using cellular systems biology yields insights into mechanisms of action","volume":"15","author":"Guiliano","year":"2010","journal-title":"J. Biomol. Screening"},{"key":"10.1016\/j.tiv.2011.04.010_b0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/019262339702500111","article-title":"Cationic amphiphilic drug-induced phospholipidosis","volume":"25","author":"Halliwell","year":"1997","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tiv.2011.04.010_b0065","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.taap.2008.01.036","article-title":"Gene expression profiling in rat liver treated with compounds inducing phospholipidosis","volume":"229","author":"Hirode","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2011.04.010_b0070","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.tiv.2008.03.016","article-title":"Proteomic analysis of phospholipidosis in citalopram treated U937 cells \u2013 Support for the cholesterol biosynthesis hypothesis","volume":"22","author":"Hutchinson","year":"2008","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2011.04.010_b0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/toxsci\/kfj067","article-title":"Establishment of an in vitro high-throughput screening assay for detecting phospholipidosis-inducing potential","volume":"90","author":"Kasahara","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2011.04.010_b0080","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0031-6997(25)00049-3","article-title":"Cationic amphiphilic drugs and phospholipid storage disorder","volume":"42","author":"Kodavanti","year":"1990","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tiv.2011.04.010_b0085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.clpt.6100479","article-title":"The state of innovation in drug development","volume":"83","author":"Kola","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2011.04.010_b0090","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/0006-2952(90)90078-Y","article-title":"Aminoglycoside-induced renal phospholipidosis and nephrotoxicity","volume":"40","author":"Laurent","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2011.04.010_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrgentox.2008.06.003","article-title":"Comparison of different methods for an accurate assessment of cytotoxicity in the in vitro micronucleus test. I. Theoretical aspects","volume":"655","author":"Lorge","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.tiv.2011.04.010_b0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0041-008X(81)90014-4","article-title":"Tamoxifen-induced generalized lipidosis in rats subchronically treated with high doses","volume":"61","author":"L\u00fcllmann","year":"1981","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2011.04.010_b0105","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0006-2952(78)90435-5","article-title":"Lipidosis induced by amphiphilic cationic drugs","volume":"27","author":"L\u00fcllmann","year":"1978","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2011.04.010_b0110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02889372","article-title":"Intraalveolar foam cells associated with lipidosis-like alterations in lung and liver of rats treated with tricyclic psychotropic drugs","volume":"19","author":"L\u00fcllmann-Rauch","year":"1975","journal-title":"Virchows Arch. B Cell. Pathol."},{"key":"10.1016\/j.tiv.2011.04.010_b0115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/15376510903322834","article-title":"Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in the rats","volume":"19","author":"Miyamoto","year":"2009","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.tiv.2011.04.010_b0120","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tiv.2008.11.010","article-title":"A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase","volume":"23","author":"Mesens","year":"2009","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2011.04.010_b0125","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.tiv.2010.04.007","article-title":"Screening for phospholipidosis induced by central nervous drugs: comparing the predictivity of an in vitro assay to high throughput in silico assays","volume":"24","author":"Mesens","year":"2010","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2011.04.010_b0130","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1517\/17425255.2.5.687","article-title":"In vitro assays and biomarkers for drug-induced phospholipidosis","volume":"2","author":"Monteith","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.tiv.2011.04.010_b0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10565-006-0176-z","article-title":"Validation of an in vitro screen for phospholipidosis using a high-content biology platform","volume":"22","author":"Morelli","year":"2006","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.tiv.2011.04.010_b0140","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/toxsci\/kfm157","article-title":"In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid-based methodologies","volume":"99","author":"Nioi","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2011.04.010_b0145","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/01480540802391229","article-title":"Monitoring the accumulation of fluorescently labeled phospholipids in cell cultures provides an accurate screen for drugs that induce phospholipidosis","volume":"31","author":"Nioi","year":"2008","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.tiv.2011.04.010_b0150","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/01926230701481956","article-title":"An immunohistochemical approach to differentiate hepatic lipidosis from hepatic phospholipidosis in rats","volume":"35","author":"Obert","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tiv.2011.04.010_b0155","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1021\/ci6004542","article-title":"Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potential","volume":"47","author":"Pelletier","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.tiv.2011.04.010_b0160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0041-008X(89)90054-9","article-title":"A review of the biology and toxicologic implications of the induction of lysosomal lamellar bodies by drugs","volume":"97","author":"Reasor","year":"1989","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.tiv.2011.04.010_b0165","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/14740338.5.4.567","article-title":"Drug-induced phospholipidosis: issues and future directions","volume":"5","author":"Reasor","year":"2006","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.tiv.2011.04.010_b0170","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/153537020122600903","article-title":"Drug-induced phospholipidosis: are there functional consequences?","volume":"226","author":"Reasor","year":"2001","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.tiv.2011.04.010_b0175","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/toxsci\/kfh264","article-title":"A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system","volume":"83","author":"Sawada","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2011.04.010_b0180","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.tiv.2006.05.009","article-title":"Improved toxicogenomic screening for drug-induced phospholipidosis using a multiplexed quantitative gene expression arrayplate assay","volume":"20","author":"Sawada","year":"2006","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2011.04.010_b0185","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/(SICI)1097-0029(19970215)36:4<253::AID-JEMT4>3.0.CO;2-N","article-title":"A review of drug induced lysosomal disorders of the liver in man and laboratory animals","volume":"36","author":"Schneider","year":"1997","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.tiv.2011.04.010_b0190","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2131\/jts.31.315","article-title":"Physicochemical and cell-based approach for early screening of phospholipidosis-inducing potential","volume":"31","author":"Tomizawa","year":"2006","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.tiv.2011.04.010_b0195","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/oxfordjournals.jbchem.a129695","article-title":"Studies on drug-induced lipidosis","volume":"70","author":"Yamamoto","year":"1971","journal-title":"J. Biochem."},{"key":"10.1016\/j.tiv.2011.04.010_b0200","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0300-483X(94)90030-2","article-title":"Ketoconazole-induced hepatic phospholipidosis in the mouse and its association with de-N-acetyl ketoconazole","volume":"94","author":"Whitehouse","year":"1994","journal-title":"Toxicology"}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233311000919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233311000919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T04:33:39Z","timestamp":1741149219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233311000919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0887233311000919"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2011.04.010","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}